Changes to the Board of Directors in Pharma Equity Group
15 Junio 2023 - 5:00AM
Changes to the Board of Directors in Pharma Equity Group
15 June 2023
Announcement no.
35
Changes to the
Board of Directors in Pharma Equity Group
Today, the company has
received notice that the Chairman of the Board of Directors, Peter
Mørch Eriksen and Board Member Ole Larsen have decided to resign
from the Board with immediate effect.
The Board has
thereafter constituted itself with Christian Vinding Thomsen as
Chairman of the Board of Directors.
For further information, please
contact:
Christian Vinding Thomsen, Chairman of
the Board of Directors of Pharma Equity Group A/S, phone: 2622
7222
Thomas Kaas Selsø, CEO of Pharma
Equity Group A/S, phone: 40 22 21 14
About Pharma Equity
Group A/S
Pharma Equity Group
A/S is a listed company on the Nasdaq Copenhagen Stock Exchange,
with a focus on early investment in innovative life science
companies (in or before phase 2) that develop technologies and
therapies that have the potential to improve human health and
quality of life.
Pharma Equity Group
A/S portfolio currently includes Reponex Pharmaceuticals A/S.
Reponex Pharmaceuticals A/S is a clinical-stage biopharmaceutical
company dedicated to the development of novel, effective treatments
for diseases that have significant patient and social
impact.
Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De May 2023 a May 2024
